Manik Amin

First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors

Johanna C. Bendell, Patricia LoRusso, Michael J. Overman et al. · Cancer Immunology Immunotherapy · 2023 · 90 citations · Full text

Safety, efficacy and pharmacodynamics (PD) of MEDI9447 (oleclumab) alone or in combination with durvalumab in advanced colorectal cancer (CRC) or pancreatic cancer (panc).

Michael J. Overman, Patricia LoRusso, John H. Strickler et al. · Journal of Clinical Oncology · 2018 · 77 citations

Immunology, Immune Regulation, Immunoediting +19

Systemic Therapy for Combined Hepatocellular-Cholangiocarcinoma: A Single-Institution Experience

Nikolaos A. Trikalinos, Amy Zhou, Maria B. Majella Doyle et al. · Journal of the National Comprehensive Cancer Network · 2018 · 66 citations · Full text

Platelet distribution width (PDW) is increased in vaso-occlusive crisis in sickle cell disease

Amit P. Amin, Manik Amin, Hemant Kulkarni · Annals of Hematology · 2004 · 45 citations

Thrombopoiesis, Thrombosis, Platelet Distribution Width +9

A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumors

Manik Amin, Susan Minton, Patricia LoRusso et al. · Investigational New Drugs · 2015 · 43 citations · Full text

Oncology, Kinase Inhibitor, Medicine +9